And that’s a wrap! Thanks to @biomelb & @dr_krystal for a fantastic event today, it’s been a blast! #biotechdev18
0
0
0
0
#biotechdev18
Latest posts tagged with #biotechdev18 on Bluesky
Trending
Posts tagged #biotechdev18
$2.6 trillion superannuation industry has a taste to invest in the #biotech sector - Darren Schultz, CFO, ISPT #biotechdev18
0
0
0
0
IP can be very flexible, and can be used in different ways, the same technology can be sliced per market and industry - Helen Fisher, CEO, @BCIFund #biotechdev18
0
0
0
0
Big opportunities in philanthropic investment, and these people are willing to invest in #biotech - Helen Woods, Development Executive @BionicsInst #biotechdev18
0
0
0
0
The #Moxidectin story: an innovative model in development and investment - thanks for sharing Danielle Smith! @MedicinesDev #biotechdev18
0
0
0
0
And these additional four months of time can increase sales dramatically - slide thanks to Danielle Smith, @MedicinesDev #biotechdev18
0
0
0
0
A “pull mechanism” to fund development is priority review vouchers, allowing #biotech companies working on neglected tropical disease drugs to have their drug reviewed by the @US_FDA within 6 months (when its usually 10+ months) - Danielle Smith, @MedicinesDev #biotechdev18
0
0
1
0
Another big pharma player here at the @biomelb event - Michael Haberl, Head of Reimbursement & Pricing at @GSK_AU talking about global payer trends for pharma and their impact on development programs #biotechdev18
0
0
0
0
Key insights: choosing the right time to spin-out, who will lead the new spin-out (scientific founder or other?), being capital raising ready and balancing resources - @HughAlsop, CEO @Kinoxis_Tx #biotechdev18
0
0
0
0
Another university spin-out story! 🎉Hearing from @HughAlsop about newly formed company @Kinoxis_Tx, with IP licenced from @Sydney_Uni #biotechdev18
0
0
0
0
Key insights: #success requires #teamwork, diverse inputs & #innovation, and there are many possible and plausible approaches - Sara Prickett, Aravax #biotechdev18
0
0
0
0
Definitely hearing a common theme today - Sara Prickett, COO Aravax, also notes the importance of sourcing the appropriate #expertise: “You don’t know what you don’t know” #biotechdev18
0
0
0
0
Spin-out superstar Darren Kelly (@Djk70) providing insight into the Certa Therapeutics journey #biotechdev18
0
0
1
0
Gearing up for part two of the Biotech Development Lab - thanks to @biomelb @DEDJTR @WatermarkIP @SeerPharma and @PrimeFinGrp for hosting and sponsoring! #biotechdev18
0
0
0
0
0
0
0
0
When the govt asked if Australia needs its own #regulatory body, it was unanimously agreed yes, especially if we want to develop the #biotech industry in Australia - John Skerritt, @TGAgovau #biotechdev18
0
0
0
0
Regulatory approval is a maze! Luckily, there is SME Assist (not just for SMEs!) offered by @TGAgovau - John Skerritt, Deputy Secretary #biotechdev18
0
0
0
0
Love the phrase from Cathy Drinkwater from @BioCurate: “Connect the ‘islands of expertise’” = get your different experts together who may be working on the same science! #biotechdev18
0
0
0
0
How @BioCurate assesses commercial projects: science is always great, but it’s also about the product, market feasibility, IP, differentiation, regulatory pathway and existing portfolio - Cathy Drinkwater, Senior Project Leader #biotechdev18
0
0
0
0
Awesome to hear that @BioCurate is looking to support the broader #biotech ecosystem @unimelb @MonashUni #biotechdev18
0
0
0
0
The bio-cluster phenomenon: #academia, #CROs, #biotech, #VC, #government & #pharma all collaborating and utilising their best competencies - Trevor Perrier, @Domainex_UK #biotechdev18
0
0
0
0
Drug discovery has been focussed on effectiveness, and not enough attention has been paid to efficiency - opinion of Trevor Perrior, CSO @Domainex_UK #biotechdev18
0
0
0
0
Key insights: commercialisation is tough, partnering is central to commercialisation and successful partnering is critical to commercialisation - Eve Williamson, Head of Global BD at Seqirus, a @CSL company #biotechdev18
0
0
0
0
The art and science of #negotiation is fundamentally about building #trust - Eve Williamson from Seqirus @csl #biotechdev18
0
0
0
0
Eve Williamson from Seqirus, a @csl company says “Sort our your IP” - I hear you! 🙌🏼 Literally half my job at @latrobe in the Commercialisation team! #biotechdev18
0
0
0
0
Partnering is a dating game - @LinkedIn is like @Tinder, and it can end in either marriage or divorce 😂 - Eve Williamson #biotechdev18
0
0
0
0
“Commercialisation is really tough! 5% chance of success at Phase I stage” - Eve Williamson #biotechdev18
0
0
0
0
Wow, what a career! Eve Williamson, Global Head of BD at Seqirus, a @CSL company #womeninSTEMau @WomenSciAUST #biotechdev18
0
0
0
0
So many advantages to take clinical trials global: access to patients, patient diversity, economic drivers, study costs, strategic partner familiarity with regulatory bodies and more! - Megan Baldwin, Opthea #biotechdev18
0
0
0
0
The US FDA approved 46 new drugs in 2017: Highest number in 21 years, and more than twice the number approved in 2016 - Megan Baldwin, Opthea #biotechdev18
0
0
0
0